LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 91.27 | 84.90 | 6297 | 7420 | 0.8486 | 0.9498 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 91.27 | 84.90 | 425 | 7420 | 0.0573 | 0.2837 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 91.27 | 84.90 | 5792 | 7420 | 0.7806 | 0.9246 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 92.98 | 84.90 | 5299 | 7257 | 0.7301 | 0.9043 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 92.98 | 84.90 | 5367 | 7257 | 0.7395 | 0.9081 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 92.98 | 84.90 | 6389 | 7257 | 0.8803 | 0.9607 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 92.98 | 84.90 | 6434 | 7257 | 0.8865 | 0.9628 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 92.98 | 84.90 | 404 | 7257 | 0.0557 | 0.2752 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 92.98 | 84.90 | 5951 | 7257 | 0.8200 | 0.9391 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 94.68 | 84.90 | 5355 | 7000 | 0.7650 | 0.9176 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 94.68 | 84.90 | 5433 | 7000 | 0.7761 | 0.9219 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 94.68 | 84.90 | 6538 | 7000 | 0.9340 | 0.9787 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 94.68 | 84.90 | 6584 | 7000 | 0.9405 | 0.9808 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 94.68 | 84.90 | 428 | 7000 | 0.0611 | 0.2893 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 94.68 | 84.90 | 6106 | 7000 | 0.8722 | 0.9575 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 2.66 | 84.90 | 8 | 285 | 0.0280 | -0.7405 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 2.66 | 84.90 | 526 | 285 | 1.8408 | 1.8339 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 2.66 | 84.90 | 707 | 285 | 2.4743 | 2.3554 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 4.36 | 84.90 | 8 | 322 | 0.0248 | -0.7067 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 4.36 | 84.90 | 605 | 322 | 1.8756 | 1.7724 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 4.36 | 84.90 | 806 | 322 | 2.4987 | 2.2177 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 6.06 | 84.90 | 12 | 365 | 0.0328 | -0.6051 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 6.06 | 84.90 | 665 | 365 | 1.8197 | 1.6576 | MN20160318_Q02 | F22 |